CLAVAMOX Comprimé (à mâcher)

국가: 캐나다

언어: 프랑스어

출처: Health Canada

유효 성분:

Amoxicilline (Trihydrate d'amoxicilline); Acide clavulanique (Clavulinate potassique)

제공처:

ZOETIS CANADA INC

복용량:

50MG; 12.5MG

약제 형태:

Comprimé (à mâcher)

구성:

Amoxicilline (Trihydrate d'amoxicilline) 50MG; Acide clavulanique (Clavulinate potassique) 12.5MG

관리 경로:

Orale

패키지 단위:

15G/50G

처방전 유형:

Prescription

치료 그룹:

Chats; Chiens

제품 요약:

Numéro de groupe d'ingrédients actifs (GIA) :0234720001

승인 상태:

APPROUVÉ

승인 날짜:

2019-06-19

환자 정보 전단

CLAVAMOX chewable tablets
Zoetis version January 28, 2020
LEAFLET
DIN 02489473
DIN 02489481
DIN 02489503
DIN 02489511
CLAVAMOX
®
_amoxicillin and clavulanate potassium chewable tablets _
_ _
Veterinary Use Only
DESCRIPTION: CLAVAMOX
®
(amoxicillin and clavulanate potassium_ _chewable
tablets) is an orally administered formulation comprised of the
broad-spectrum antibiotic
amoxicillin (as amoxicillin trihydrate) and the β-lactamase inhibitor
clavulanic acid (as
clavulanate potassium).
MEDICINAL INGREDIENTS:
-
Each 62.5 mg chewable tablet strength contains 50 mg amoxicillin (as
amoxicillin
trihydrate) and 12.5 mg clavulanic acid (as clavulanate potassium).
-
Each 125 mg chewable tablet strength contains 100 mg amoxicillin (as
amoxicillin
trihydrate) and 25 mg clavulanic acid (as clavulanate potassium).
-
Each 250 mg chewable tablet strength contains 200 mg amoxicillin (as
amoxicillin
trihydrate) and 50 mg clavulanic acid (as clavulanate potassium).
-
Each 375 mg chewable tablet strength contains 300 mg amoxicillin (as
amoxicillin
trihydrate) and 75 mg clavulanic acid (as clavulanate potassium).
INDICATIONS: CLAVAMOX chewable tablets are indicated for the treatment
of:
DOGS:
_Skin and Soft Tissue Infections _such as wounds, abscesses,
cellulitis, superficial/juvenile
and deep pyoderma due to susceptible strains of the following
bacteria:
• β-lactamase-producing _Staphylococcus aureus _
• non- β-lactamase-producing _Staphylococcus aureus _
• _Staphylococcus _spp., _Streptococcus _spp., and _E. coli _
_Urinary Tract Infections _(cystitis) due to susceptible strains of
_E. coli_.
_Gingivitis associated with periodontal infections _due to susceptible
strains of aerobic and
anaerobic bacteria.
CATS: _Skin and Soft Tissue Infections _such as wounds, abscesses, and
cellulitis/dermatitis due to susceptible strains of the following
bacteria:
• β-lactamase-producing _Staphylococcus aureus _
• non- β-lactamase-producing _Staphylococcus aureus _
• _Staphylococcus _spp., _Streptococcus _spp., _E. coli_, and
_P